In a study known as CROWNS-2 published in JAMA, the researchers randomly assigned 180 adults with CRSwNP to stapokibart (300 ...

The FDA has approved semaglutide for treating MASH, a significant advancement in liver disease management. Semaglutide, ...

One promising option is turmeric, a bright yellow spice commonly used in cooking. Its active compound, curcumin, has shown ...